Search Within

Gregory J Riely

Formats
  1. Journal Article (295)
  2. Meeting Abstract (265)
  3. Book Section (16)
  4. Guidelines (15)
  5. Conference Paper (4)
  6. Review (4)
  7. Editorial (3)
  8. Book Whole (1)
  9. Correspondence (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (605)
  2. Solid Tumor Oncology Division (605)
  3. Thoracic Oncology (605)
  4. Department of Pathology and Laboratory Medicine (262)
  5. GSK Faculty (248)
  6. Human Oncology and Pathogenesis Program (223)

More Groups

People
  1. Mark Kris (222)
  2. Marc Ladanyi (188)
  3. Helena Yu (108)
  4. Maria Arcila (85)
  5. Vincent Miller (79)
  6. Charles Rudin (76)

More People

Years
  1. 2025 (9)
  2. 2024 (25)
  3. 2023 (45)
  4. 2022 (39)
  5. 2021 (41)
  6. 2020 (29)

More Years

Publications
  1. Journal of Clinical Oncology (157)
  2. Journal of Thoracic Oncology (113)
  3. Clinical Cancer Research (46)
  4. Annals of Oncology (32)
  5. Journal of the National Comprehensive Cancer Network (26)
  6. Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (175)
  2. Elsevier Inc. (137)
  3. American Association for Cancer Research (77)
  4. Oxford University Press (39)
  5. Harborside Press (26)
  6. Elsevier Science, Inc. (23)

More Publishers

Results (605)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Erlotinib and trametinib in patients with EGFR-mutant lung adenocarcinoma and acquired resistance to a prior tyrosine kinase inhibitor
    Journal Article

    Luo, J.; Makhnin, A.; Tobi, Y.; Ahn, L.; Hayes, S. A.; Iqbal, A.; Ng, K.; Arcila, M. E.; Riely, G. J.; Kris, M. G.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Long-term outcomes and characteristics of unresectable locally advanced thymic malignancies
    Meeting Abstract

    Sideris, A.; Li, X.; Oufkir, H.; Curry, M.; Tan, K. S.; Araujo-Filho, J.; Robinson, E.; Jones, D.; Ginsberg, M.; Rimner, A.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Mobocertinib in platinum-pretreated EGFR exon 20 insertion+ metastatic NSCLC patients with/without prior anti-PD(L)-1 therapy
    Meeting Abstract

    Janne, P.; Ramalingam, S.; Kim, T.; Yang, J. C.; Riely, G.; Mekhail, T.; Nguyen, D.; Campelo, M. R. G.; Felip, E.; Jin, S.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Mobocertinib (TAK-788) in EGFR exon 20 insertion+ metastatic NSCLC: Patient-reported outcomes from EXCLAIM extension cohort
    Meeting Abstract

    García Campelo, M. R.; Zhou, C.; Ramalingam, S.; Lin, H.; Kim, T.; Riely, G.; Mekhail, T.; Nguyen, D.; Goodman, E.; Le, K.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Mobocertinib in EGFR exon 20 insertion-positive metastatic NSCLC patients with disease control on prior EGFR TKI therapy
    Meeting Abstract

    Spira, A.; Ramalingam, S.; Neal, J.; Piotrowska, Z.; Mekhail, T.; Tsao, A.; Gentzler, R.; Riely, G.; Bazhenova, L.; Gadgeel, S.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Mobocertinib (TAK-788) in EGFR exon 20 insertion (ex20ins)+ metastatic NSCLC (mNSCLC): Additional results from platinum-pretreated patients (pts) and EXCLAIM cohort of phase 1/2 study
    Meeting Abstract

    Ramalingam, S. S.; Zhou, C.; Kim, T. M.; Kim, S. W.; Yang, J. C. H.; Riely, G. J.; Mekhail, T.; Nguyen, D.; Campelo, M. R. G.; Felip, E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinical and genomic predictors of brain metastases (BM) in non-small cell lung cancer (NSCLC): An AACR Project GENIE analysis
    Meeting Abstract

    Rahman, P.; LeNoue-Newton, M.; Chaugai, S.; Holt, M.; Jain, N. M.; Maxwell, C.; Micheel, C.; Yang, Y. J.; Ye, C.; Schultz, N.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Pan-cancer evaluation of homologous repair deficiency somatic mutations and response to first-line anti-neoplastic therapy
    Meeting Abstract

    Lavery, J. A.; Brown, S.; Riely, G. J.; Bedard, P. L.; Park, B. H.; Warner, J. L.; Kehl, K. L.; Lepisto, E. M.; Rizvi, H.; LeNoue-Newton, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Chemo-immunotherapy outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer
    Meeting Abstract

    Arbour, K. C.; Ricciuti, B.; Rizvi, H.; Hellmann, M. D.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; Arcila, M. E.; Rudin, C. M.; Lito, P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Genomic alterations of bone metastases in stage IV non-small cell lung cancer (NSCLC) and real-world outcomes
    Meeting Abstract

    Voon, P. J.; Riely, G. J.; Lepisto, E. M.; Lavery, J. A.; Warner, J. L.; LeNoue-Newton, M. L.; Sweeney, S. M.; McCarthy, C. G.; Samantha, B.; Panageas, K. S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save